Apria Healthcare Group (AHG) –
-
Form 6-K Akso Health Group For: Mar 26
-
Form 6-K Akso Health Group For: Mar 08
-
Form 424B5 Akso Health Group
-
Form F-3 Akso Health Group
-
Apria Healthcare Group (AHG) to Acquire Online Clinic
-
AHG Announces Plan to Acquire Online Clinic
-
AHG Announces Plan to Acquire Online Clinic
-
Form 6-K Akso Health Group For: Jan 29
-
Form 6-K Akso Health Group For: Jan 19
-
Form 6-K Akso Health Group For: Sep 30
-
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.07%
-
Form 6-K Akso Health Group For: Nov 22
-
Form 6-K Akso Health Group For: Nov 17
-
Form 6-K Akso Health Group For: Oct 18
-
Apria Healthcare Group (AHG) Regains Compliance with Nasdaq's Minimum Bid Price Requirement
-
Akso Health Group Regains Compliance with Nasdaq's Minimum Bid Price Requirement
-
Akso Health Group Regains Compliance with Nasdaq's Minimum Bid Price Requirement
-
Form 6-K Akso Health Group For: Oct 02
-
Form 20-F Akso Health Group For: Mar 31
-
Form 6-K Akso Health Group For: Jun 23
-
Form 6-K Akso Health Group For: May 25
-
Form 6-K Akso Health Group For: May 18
-
Akso Health Group Granted Additional 180 Calendar Day Grace Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule
-
Akso Health Group Granted Additional 180 Calendar Day Grace Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule
-
Apria Healthcare Group (AHG) Receives Nasdaq Deficiency Notice
-
Akso Health Group Received Nasdaq Notification Letter Regarding Stockholders' Equity Deficiency
-
Akso Health Group Received Nasdaq Notification Letter Regarding Stockholders' Equity Deficiency
-
Form 6-K Akso Health Group For: Sep 30
-
Form 20-F Akso Health Group For: Mar 31
-
Form 6-K Akso Health Group For: Nov 01
-
Apria Healthcare Group (AHG) Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
Akso Health Group Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
Form 6-K Akso Health Group For: Oct 14
-
Apria Healthcare Group (AHG) Receives Notice of Filing Delinquency From Nasdaq
-
Akso Health Group Receives Notice of Filing Delinquency From Nasdaq
-
Form NT 20-F Akso Health Group For: Mar 31
-
Form 6-K Akso Health Group For: Jun 10
-
Form 6-K Akso Health Group For: Apr 15
-
Akso Health Group Announces Effective Date of Name Change and Ticker Symbol Change
-
Akso Health Group Reports Unaudited Financial Results for First Half of Fiscal Year 2022
-
European High Growth Opportunities Securitization Fund Converts Debentures of Alternate Health Corp.
-
CORRECTING and REPLACING – European High Growth Opportunities Securitization Fund Converts Debentures of Alternate Health Corp.
-
European High Growth Opportunities Securitization Fund Converts Debentures of Alternate Health Corp.
-
European High Growth Opportunities Securitization Fund Closes Second Tranche of Financing Arrangement with Alternate Health Corp.
-
Alternate Health to Launch Cannabis Extraction at 60,000 SF State Licensed Facility in California
-
Alternate Health Announces Private Placement
-
Kyle Kemper Joins Alternate Health's Board of Directors
-
Alternate Health Secures Second Set of Licenses for Cannabis Manufacturing and Distribution in Los Angeles
-
Alternate Health Appoints Howard Mann as New CEO
-
Alternate Health Announces Private Placement Closing
Back to AHG Stock Lookup